Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

Tea tree oil in the treatment of tinea pedis.

Tong MM, Altman PM, Barnetson RS.

Australas J Dermatol. 1992;33(3):145-9.

PMID:
1303075
2.

Treatment of interdigital tinea pedis with 25% and 50% tea tree oil solution: a randomized, placebo-controlled, blinded study.

Satchell AC, Saurajen A, Bell C, Barnetson RS.

Australas J Dermatol. 2002 Aug;43(3):175-8.

PMID:
12121393
3.

Burnaid.

Price J.

Burns. 1998 Feb;24(1):80-2. No abstract available.

PMID:
9601599
4.

A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne.

Bassett IB, Pannowitz DL, Barnetson RS.

Med J Aust. 1990 Oct 15;153(8):455-8.

PMID:
2145499
5.

Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream.

Syed TA, Qureshi ZA, Ali SM, Ahmad S, Ahmad SA.

Trop Med Int Health. 1999 Apr;4(4):284-7.

6.

The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study.

Enshaieh S, Jooya A, Siadat AH, Iraji F.

Indian J Dermatol Venereol Leprol. 2007 Jan-Feb;73(1):22-5.

7.
8.

Topical tea tree oil effective in canine localised pruritic dermatitis--a multi-centre randomised double-blind controlled clinical trial in the veterinary practice.

Reichling J, Fitzi J, Hellmann K, Wegener T, Bucher S, Saller R.

Dtsch Tierarztl Wochenschr. 2004 Oct;111(10):408-14.

PMID:
15568640
9.

Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.

Ortonne JP, Korting HC, ViguiƩ-Vallanet C, Larnier C, Savaluny E.

J Eur Acad Dermatol Venereol. 2006 Nov;20(10):1307-13.

PMID:
17062050
10.

Efficacy and safety of tea tree oil as a topical antimicrobial agent.

Carson CF, Riley TV, Cookson BD.

J Hosp Infect. 1998 Nov;40(3):175-8. Review. No abstract available.

PMID:
9830588
11.

Comparison between undecylenic acid and tolnaftate in the treatment of tinea pedis.

Fuerst JF, Cox GF, Weaver SM, Duncan WC.

Cutis. 1980 May;25(5):544-6, 549.

PMID:
6991217
12.

Double-blind study of the efficacy of 1 week topical terbinafine cream compared to 4 weeks miconazole cream in patients with tinea pedis.

Leenutaphong V, Niumpradit N, Tangwiwat S, Sritaveesuwan R, Muanprasat C.

J Med Assoc Thai. 1999 Oct;82(10):1006-10.

PMID:
10561963
13.

Tea tree oil reduces histamine-induced skin inflammation.

Koh KJ, Pearce AL, Marshman G, Finlay-Jones JJ, Hart PH.

Br J Dermatol. 2002 Dec;147(6):1212-7.

PMID:
12452873
14.

Antifungal activity of tea tree oil from Melaleuca alternifolia against Trichophyton equinum: an in vivo assay.

Pisseri F, Bertoli A, Nardoni S, Pinto L, Pistelli L, Guidi G, Mancianti F.

Phytomedicine. 2009 Nov;16(11):1056-8. doi: 10.1016/j.phymed.2009.03.013. Epub 2009 Apr 28.

PMID:
19403294
15.

A clinical trial of topical terbinafine (a new allylamine antifungal) in the treatment of tinea pedis.

Smith EB, Noppakun N, Newton RC.

J Am Acad Dermatol. 1990 Oct;23(4 Pt 2):790-4.

PMID:
2229525
16.

Comparison of over-the-counter agents for tinea pedis.

Tschen EH, Becker LE, Ulrich JA, Hoge WH, Smith EB.

Cutis. 1979 May;23(5):696-8.

PMID:
378561
17.

Efficacy and safety of short-term itraconazole in tinea pedis: a double-blind, randomized, placebo-controlled trial.

Svejgaard E, Avnstorp C, Wanscher B, Nilsson J, Heremans A.

Dermatology. 1998;197(4):368-72.

PMID:
9873176
18.

Oral administration of bovine lactoferrin for treatment of tinea pedis. A placebo-controlled, double-blind study.

Yamauchi K, Hiruma M, Yamazaki N, Wakabayashi H, Kuwata H, Teraguchi S, Hayasawa H, Suegara N, Yamaguchi H.

Mycoses. 2000;43(5):197-202.

PMID:
10948819
19.
20.

Ciclopirox gel in the treatment of patients with interdigital tinea pedis.

Aly R, Fisher G, Katz I, Levine N, Lookingbill DP, Lowe N, Menter A, Morman M, Pariser DM, Roth HL, Savin RC, Shavin JS, Stewart D, Taylor JR, Tucker S, Wortzman M.

Int J Dermatol. 2003 Sep;42 Suppl 1:29-35.

PMID:
14567368

Supplemental Content

Support Center